ARase Therapeutics
2 known investors
Arase Therapeutics develops first-in-class oncology therapeutics that target ADP-ribose Hydrolases, novel proteins in cancer stress pathways. The company focuses on developing new cancer treatments for patients with various cancer types.
Founders & leadership
PC
Paul ChangPresident, CEO / CSO and Lead Founder
WL
W. Lee KrausScientific Founder
MT
Investors · 2
Competitors · 6
by search overlap
Atara Biotherapeutics6 shared keywordsAtara Biotherapeutics develops allogeneic T-cell immunotherapies using its proprietary EBV T-cell platform to harness the immune system for treating disease. The company focuses on next-generation cell-based therapies designed for patients worldwide.
Aro Biotherapeutics4 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Sarepta Therapeutics4 shared keywordsSarepta develops precision genetic medicines for people with rare diseases, with a focus on rare neuromuscular conditions. The company also runs an investigator-initiated studies program that funds independent clinical and non-clinical research in its therapeutic areas.
Tessera3 shared keywordsTessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases. The company focuses on non-viral delivery methods to enable potentially curative genetic therapies.
Protara Therapeutics3 shared keywordsProtara Therapeutics is a clinical-stage biopharmaceutical company developing investigational therapies, including a cell therapy for non-muscle invasive bladder cancer and lymphatic malformations, and an IV choline replacement therapy for patients on parenteral support.
Samsara Biocapital3 shared keywordsSamsara Capital is an investment firm that backs the development of therapeutics for patients. It brings together scientists, physicians, drug developers, and business leaders to support next-generation therapeutic breakthroughs.
Companies competing with ARase Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ARase Therapeutics do?
- Arase Therapeutics develops first-in-class oncology therapeutics that target ADP-ribose Hydrolases, novel proteins in cancer stress pathways. The company focuses on developing new cancer treatments for patients with various cancer types.
- Who founded ARase Therapeutics?
- ARase Therapeutics was founded by Paul Chang, W. Lee Kraus.
- Who are ARase Therapeutics's investors?
- ARase Therapeutics's investors include Mission Biocapital, Portal Innovations.